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Akt Phosphorylation of BAD Couples Survival
Signals to the Cell-Intrinsic Death Machinery
suppress the ability of trophic factors to promote sur-
vival; conversely, in many cell types PI39K activity is
sufficient topromote survival (Scheid et al., 1995; Vemuri
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Xu Tao,* Shane Masters,² Haian Fu,²
Yukiko Gotoh,* and Michael E. Greenberg*³
and McMorris, 1996; Yao and Cooper, 1995, 1996;*Division of Neuroscience
D'Mello et al., 1997; Dudek et al., 1997). There are aChildren's Hospital and
number of PI39K isoforms, the most well-characterizedDepartment of Neurobiology
of which is a heterodimer composed of an 85 kDaregula-Harvard Medical School
tory subunit and a catalytic 110 kDa subunit. The bestBoston, Massachusetts 02115
elucidated mechanism by which growth factors activate²Department of Pharmacology and
PI39K involves the association of the p85 subunit withThe Graduate Program of Molecular Therapeutics
specific phosphotyrosines on either the cytoplasmic do-and Toxicology
main of growth factor receptors or on receptor-associ-Emory University School of Medicine
ated adapter proteins. PI39K may also directly interactAtlanta, Georgia 30322
with and be activated by the small G protein Ras (Kodaki
et al., 1994; Rodriguez-Viciana et al., 1994, 1996). Thus,
through several possible protein±protein interactions,Summary
growth factor receptor activation recruits PI39K to the
membrane where the PI39K p110 subunit phosphory-Growth factors can promote cell survival by activating
lates phosphoinositides at the D-3 position. PI39K-gen-the phosphatidylinositide-39-OH kinase and its down-
erated phospholipids then elicit a diverse set of cellularstream target, the serine-threonine kinase Akt. How-
responses (reviewed in Carpenter and Cantley, 1996).ever, the mechanism by which Akt functions to pro-
One target of PI39K is the serine-threonine kinasemote survival is not understood. We show that growth
c-Akt, also known as PKB (protein kinase B) and RAC-factor activation of the PI39K/Akt signaling pathway
PK (related to A and C protein kinase). c-Akt (or RACa)culminates in the phosphorylation of the BCL-2 family
is the prototypical member of a family of mammalianmember BAD, thereby suppressing apoptosis and pro-
Akt isoforms that includes RACb and RACg (Bellacosamoting cell survival. Akt phosphorylates BAD in vitro
et al., 1991; Jones et al., 1991; Coffer and Woodgett,and in vivo, and blocks the BAD-induced death of pri-
1992; Konishi et al., 1995). Akt may be regulated by bothmary neurons in a site-specific manner. These findings
phosphorylation and by the direct binding of PI39K lipiddefine a mechanism by which growth factors directly
products to the Akt pleckstrin homology (PH) domain.inactivate a critical component of the cell-intrinsic
Other mechanisms of Akt activation may also exist,death machinery.
as PI39K-independent Akt stimuli have been identified
(Burgering and Coffer, 1995; Franke et al., 1995, 1997;Introduction
Alessi et al., 1996, 1997; Datta et al., 1996; Kohn et al.,
1996; Didichenko et al., 1996; Klippel et al., 1997).
Regulation of cell survival is crucial to the normal physi-
Akt is a general mediator of growth factor±induced
ology of multicellular organisms. The appropriate sup-
survival and has been shown to suppress the apoptotic
pression of cell death is important in a number of con-
death of a number of cell types induced by a variety of
texts, ranging from the sculpting of the nervous system
stimuli, including growth factor withdrawal, cell-cycle
during development to adaptive responses during adult-
discordance, loss of cell adhesion, and DNA damage
hood. In addition, perturbation of normal survival mech- (Ahmed et al., 1997; Dudek et al., 1997; Kauffmann-Zeh
anismsÐleading to either excessive cell death or sur-
et al., 1997; Kennedy et al., 1997; Khwaja et al., 1997;
vivalÐmay play a role in a large number of disease
Kulik et al., 1997). Thus, a signaling pathway has been
processes.
defined in which growth factor receptor activation leads
A number of well-characterized peptide factors pro- to the sequential activation of PI39K and Akt, which then,
mote cell survival, including the neurotrophins and growth through as-yet undescribed mechanisms, promotes cell
factors such as insulin-like growth factor I (IGF-1) and survival and blocks apoptosis.
platelet-derived growth factor (PDGF) (Segal and Green- An unanswered question is how activation of the
berg, 1996; Stewart and Rotwein, 1996; reviewed in Ata- PI39K/Akt signaling pathway promotes cell survival and
liotis and Mercola, 1997). The characterization of signal suppresses apoptosis. Known in vivo substrates for Akt
transduction pathways activated by these factors has include the glycogen synthase kinase-3, and possibly
led to the identification of proteins that are critical medi- the p70 ribosomal S6 kinase, although neither of these
atorsof cell survival. Forexample, the phosphatidylinosi- proteins has yet been shown to play a role in cell survival
tide-39-OH kinase (PI39K) has been recently shown to be (Burgering and Coffer, 1995; Cross et al., 1995; Franke
involved in thesurvival of a number of different cell types. et al., 1995; Alessi et al., 1996; Kohn et al., 1996). One
Pharmacologic or genetic blockade of PI39K activity can mechanism by which Akt may promote survival is
through the inhibition of a component of the cell death
machinery. Among molecules central to the regulation³To whom correspondence should be addressed.
of cell death in eukaryotes are members of the BCL-2§Present Address: Ontogeny, Inc., 45 Moulton St., Cambridge, Mas-
sachusetts 02138. family of proteins. The C. elegans protein CED-9 and its
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mammalian proto-oncogene homolog BCL-2 have been
shown by genetic means to promote cell survival. Sev-
eral members of the BCL-2 family (including BCL-2,
BCL-XL, MCL-1, A1, and BAG-1) promote survival while
other members (including BCL-XS, BAD, BAX, and BAK)
promote cell death. BCL-2 family proteins homo- and
heterodimerize, and the balance between particular
homo- and heterodimers is thought to be critical to the
maintenance of cell survival or the induction of death.
The mechanisms by which BCL-2 family members func-
tion are not well understood, but may include the forma-
tion of ion channels and the regulation of proteases
involved in programmed cell death (Hengartner and Hor-
vitz, 1994; reviewed in Boise et al., 1995; Steller, 1995;
Chinnaiyan and Dixit, 1996; Merry and Korsmeyer, 1997;
Reed, 1997).
It is not known how the activity of BCL-2 family mem-
bers is regulated by specific signal transduction mole-
cules that are activated by survival signals. One possibil-
ity is that growth factor±regulated protein kinases
phosphorylate a BCL-2 family member and regulate its
function. One likely target of phosphorylation by growth
factor±regulated kinases is the BCL-2 family member
BAD (Yang et al., 1995). BAD function is modulated by
phosphorylation at two sites, serine 112 (Ser-112) and
serine 136 (Ser-136) (Gajewski and Thompson, 1996; Figure 1. Akt Phosphorylates BAD In Vitro
Wang et al., 1996; Zha et al., 1996). In hematopoietic (A) Expressed Akt phosphorylates recombinant BAD in an immuno-
cells the cytokine Il-3, under conditions where it pro- complex kinase assay. Immunocomplex kinase assay using anti-
HA immunoprecipitates (12CA5 MAb) of hemagglutanin-tagged Aktmotes cell survival, induces the phosphorylation of BAD
constructs expressing CMV-6 control (Vector), constitutively activeat Ser-112 and Ser-136. In the absence of phosphoryla-
HA-mD4-129Akt (Active Akt), HA-Akt (Wild-type Akt), or kinase-inac-tion of these sites, BAD is thought to induce cell death,
tive HA-AktK179M (Inactive Akt) expressed in Balb/c 3T3 cells, HEK
possibly via the formation of heterodimers with BCL-XL 293 cells, or COS-7 cells using recombinant wild-type BAD (100 ng/
and the concomitant generation of BAX homodimers. rxn) as a substrate. Immunoblotting revealed that cells expressed
In contrast, the Il-3-mediated phosphorylation of either Akt constructs equally.
(B) Activated endogenous Akt phosphorylates BAD in a PI39K-depen-the Ser-112 or the Ser-136 site may promote the survival
dent manner. Immunocomplex kinase assay using endogenous Aktof hematopoietic cells. Phosphorylation has been corre-
immunoprecipitated (Santa Cruz anti-Akt1) from equal amounts oflated with binding of BAD to the 14-3-3t protein, which
protein extracted from starved and PDGF-stimulated Balb/c 3T3
may sequester BAD from BCL-XL, thus promoting cell cells using recombinant BAD (100 ng/rxn) as a substrate. Cells were
survival. However, the kinases that catalyze BAD phos- pretreated for 45 min with either vehicle, wortmannin, (20 nM), or
phorylation and thereby promote cell survival have not LY 294002 (10 mM).
been characterized.
We hypothesized that thePI39K/Akt pathway may lead
factors on cell survival are often mediated by the PI39K/to BAD phosphorylation and may thereby suppress cell
Akt signaling pathway, we asked whether Akt might pro-death and promote cell survival. In this report, we show
mote survival by phosphorylating BAD.that Akt phosphorylates BAD at Ser-136 in vitro and in
vivo. In addition, IGF-1 and Akt function to block BAD-
The PI39K-Dependent Kinase Akt Phosphorylatesmediated death by phosphorylating BAD at Ser-136.
BAD at Ser-136 In VitroThese findings reveal a mechanism by which a growth
To test whether Akt functions as a BAD kinase in vitro,factor±regulated kinase cascade that mediates cell sur-
wild-type or mutant forms of hemagglutanin-tagged Aktvival inhibits the death-promoting activity of a compo-
were expressed in a variety of cell lines, immunopre-nent of the intrinsic cell death machinery.
cipitated with an anti-HA antibody, and assayed in an
immunocomplex kinase assay for their ability to phos-
phorylate recombinant BAD. Akt constructs that wereResults
expressed in cells included hemagglutanin-tagged wild-
type Akt (HA-Akt), an Akt derivative rendered constitu-By using peptides derived from the site on GSK-3 known
to be phosphorylated by Akt, it was recently established tively active by targeting it to the plasma membrane with
a myristoyl tag (HA-mD4-129Akt), and an Akt derivativethat Akt preferentially phosphorylates substrates that
conform to the sequence RXRXXS (Alessi et al., 1996). rendered kinase-inactive by point mutation within the
Akt catalytic domain (HA-AktK179M) (Franke et al., 1995;Both the Ser-112 (RSRHSS) and Ser-136 (RGRSRS)
phosphorylation sites on BAD conform to this general Kohn et al., 1996; Dudek et al., 1997). As shown in Figure
1A, anti-HA immunoprecipitates prepared from cellsconsensus sequence (Zha et al., 1996). Based upon this
observation and the finding that the effects of growth transfected with constitutively active Akt or, to a lesser
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extent, wild-type Akt were found to induce BAD phos-
phorylation in immunocomplex kinase assays. Anti-HA
immunoprecipitates from cells transfected with vector
or the kinase-inactive Akt failed to phosphorylate BAD
significantly. In addition, endogenous Akt immunopre-
cipitated from 3T3 cells stimulated with PDGF, but not
Akt immunoprecipitated from starved cells, phosphory-
lated BAD (Figure 1B). Consistent with a role for the
PI39K/Akt pathway in BAD phosphorylation in vitro, pre-
treatment of cells with the wortmannin, an irreversible
inhibitor of PI39K, or LY 294002, a structurally unrelated
PI39K inhibitor, before PDGF stimulation blocked Akt
phosphorylation of BAD in an immunocomplex kinase
assay (Figure 1B).
Previous experiments established that there are two
phosphorylation sites that regulate BAD function, the Ser-
112 site (RSRHSpSYP) and the Ser-136 site (RQRSTpSTP)
(Zha et al., 1996). These are the only sites within BAD
that correspond to the defined RXRXXS Akt consensus
phosphorylation sequence. To facilitate the identifica-
tion of the Akt phosphorylation site on BAD, recombi-
nant BAD mutant proteins were generated in which Ser-
112 (BADS112A), Ser-136 (BADS136A), or both (BAD2SA)
were converted to alanine so that BAD could no longer
be phosphorylated at these sites. Mutation of these sites
Figure 2. Akt Phosphorylates BAD at Serine 136 In Vitrohad no effect on the levels of expression of these pro-
(A) Expressed Akt phosphorylates recombinant BAD andteins in either E. coli oreukaryotic cells, and the mutation
BADS112A, andnot BADS136A or BAD2SA. Immunocomplex kinaseof individual sites did not disrupt the ability of BAD to
assay using anti-HA immunoprecipitates (12CA5 MAb) from Balb/cbind to 14-3-3b in vitro (data not shown).
3T3 cells transfected with hemagglutanin-tagged Akt constructs
To test the importanceof BAD Ser-112 and Ser-136 for expressing CMV-6 vector control (Vector), HA-Akt (Wild-type Akt),
Akt-mediated BAD phosphorylation in vitro, cells were kinase-inactive HA-AktK179M (Inactive Akt), and constitutively ac-
transfected with various Akt expression constructs, and tive Akt HA-mD4-129Akt (Active Akt) using recombinant wild-type
BAD (WT BAD), BADS112A, BADS136A, or BAD2SA as substratesthe ability of immunoprecipitated Akt derivatives to
(100 ng/rxn). Experiments were performed after 6 hr of serum starva-phosphorylate wild-type BAD and various BAD phos-
tion followed by injection of either control PBS (2 PDGF) or 20 ng/phorylation site mutants was assessed. As shown in Fig-
ml PDGF (1 PDGF).
ure 2A, Akt activation resulted in the phosphorylation (B) Protein kinase A phosphorylates mainly Ser-112. Kinase assay
of wild-type BAD and the phosphorylation of BAD con- using recombinant wild-type BAD, BADS112A, BADS136A, and
taining a Ser-112 mutation. In contrast, 32P incorporation BAD2SA (100 ng/rxn) as substrates and purified PKA (Boehringer
Mannheim, 4 mU) as an in vitro kinase.was not evident in BADS136A or in BAD2SA, indicating
that the BAD Ser-136 phosphoacceptor site is critical
to Akt-mediated BAD phosphorylation. In addition, Akt identically to a ninhydrin-stained synthetic phospho-
isolated from PDGF-stimulated 3T3 cells or NGF-stimu- peptide corresponding to the predicted BAD tryptic
lated PC12 cells significantly induced the phosphory- fragment that includes BAD Ser-136 (Figure 3A, left
lation of a peptide substrate composed of the BAD panels). Tryptic maps of Akt-phosphorylated BADS112A
sequence encompassing Ser-136, but only slightly in- protein appeared identical to maps of wild-type BAD
duced the phosphorylation of a peptide composed of (data not shown); in contrast, mutation of the BAD
the BAD sequence surrounding Ser-112 (data not shown). Ser-136 site, either in the context of BADS136A protein
To verify that mutation of the BAD Ser-136 site did not or BAD2SA protein, resulted in maps devoid of any de-
disrupt the conformation of the BADS136A protein and tectable 32P, indicating that the BAD Ser-136 site is
render it refractory to all phosphorylation, the BAD required for Akt to phosphorylate BAD (Figure 3A, right
proteins were coincubated with purified PKA and (g 32P) panels). As a control, BAD phosphorylated with PKA
ATP in vitro. PKA phosphorylated wild-type BAD and was also subjected to tryptic 2-D mapping, and tryptic
BADS136A to the same extent in vitro but poorly phos- fragment migration was compared to the 2-D migration
phorylated BADS112A and BAD2SA, consistent with the of a synthetic phosphopeptide containing the putative
previous identification of BAD Ser-112 as a major PKA BAD Ser-112 tryptic fragment. The BAD Ser-112 tryptic
phoshporylation site (Zha et al., 1996) (Figure 2B). peptide and the BAD Ser-112 synthetic peptide mi-
To further characterize the sites in BAD phosphory- grated similarly, and the BAD Ser-112 peptide migrated
lated by Akt, tryptic fragments of wild-type and mutant quite differently from the tryptic fragment containing
BAD proteins that had been phosphorylated by acti- BAD Ser-136 (Figure 3A, middle panels). These experi-
vated Akt in vitro were subjected to two-dimensional ments suggest, therefore, that BAD Ser-136 is the major
mapping analysis. Two-dimensional maps of 32P-labeled site for BAD phosphorylation by Akt.
tryptic fragments of wild-type BAD revealed one major To unequivocally identify BAD Ser-136 as a site in-
volved in Akt-mediated BAD phosphorylation in vitro, aphosphopeptide spot. This tryptic peptide migrated
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proteins in which Ser-136 was changed to an alanine.
In parallel control experiments, the anti-BAD136 pAb
failed to recognize unphosphorylated forms of BAD,
BADS112A, BADS136A, and BAD2SA, and failed to rec-
ognize BAD Ser-136 mutants that had been phosphory-
lated at Ser-112 by PKA. These control experiments
demonstrate that the anti-BAD136 pAbs recognize only
BAD phosphorylated at Ser-136, and do not recognize
BAD phosphorylated at Ser-112. Therefore through the
use of phosphospecific antisera we have demonstrated
that Akt phosphorylates BAD Ser-136 in vitro.
The PI39K-Akt Pathway Leads to BAD Ser-136
Phosphorylation In Vivo
We next examined the importance of the PI39K-Akt path-
way for the phosphorylation of BAD in vivo. In these
experiments, we took advantage of the previous finding
that BAD phosphorylated on both Ser-112 and Ser-136
undergoes a shift in mobility on SDS±PAGE gels, due
to the appearance of a more slowly migrating form of
BAD (Wang et al., 1996; Zha et al., 1996). For example,
BAD protein isolated from Il-3-treated hematopoietic
cells that had been stably transfected with BAD expres-
sion constructs ran as a doublet on SDS±PAGE gels;
this doublet resolved to a monomer after potato acid
phosphatase treatment, strongly suggesting that this
shift was the result of a phosphorylation event. Muta-
tional analysis revealed that both Ser-112 and Ser-136
were required for this phosphorylation shift (Wang et
Figure 3. Phosphotryptic and Phosphopeptide Analyses Demon- al., 1996; Zha et al., 1996). We assayed the in vivo phos-
strate That Akt Phosphorylates BAD at Ser-136
phorylation status of endogenous BAD using this shift
(A) Akt phosphorylates one major tryptic peptide. 2-D maps of tryptic
assay. Brief exposure of Balb/c 3T3 cells to platelet-fragments of recombinant BAD phosphorylated by Akt were gener-
derived growth factor (PDGF), which is a potent survivalated by immunoprecipitating a constitutively active Akt expressed
factor for a number of cell types, induced a shift in BADin transfected Balb/c 3T3 cells, phosphorylating wild-type BAD (WT
BAD-Akt, upper left panel), BADS136A (BADS136A-Akt, upper right migration on SDS±PAGE (Figure 4A). A similar shift in
panel), or BAD2SA (BAD2SA-Akt, lower right panel), and trypsinizing migration was observed in BAD isolated from PC12 cells
the proteins. Fragments were separated using electrophoresis in treated with the survival factor NGF (data not shown).
the horizontal dimension (pH 8.9) and chromatography in the vertical
Thus, in the absence of survival factors, endogenousdimension. TLC plates were then subjected to autoradiography. An
BAD is less phosphorylated, and when survival factorsidentical protocol was used to generate a map for BAD phosphory-
such as Il-3, PDGF or NGF are added to cells, BADlated by purified PKA (WT BAD-PKA, lower left panel). Mobility of
synthetic phosphopeptides containing the predicted BAD Ser-136 becomes newly phosphorylated within minutes, as indi-
tryptic fragment (pSAPPNLWAARQ; pSer-136 Peptide, upper mid- cated by its slower migration on SDS±PAGE.
dle panel), and the predicted BAD Ser-112 tryptic fragment (HSpSY- We next tested the possibility that growth factors trigger
PAGTEEDEGMEEELSPFR; pSer-112 Peptide, lower middle panel)
BAD phosphorylation in a PI39K/Akt pathway±depen-were subjected to similar TLC separation and detected by ninhydrin
dent manner. Consistent with this possibility, treatmentstaining.
of cells with wortmannin or LY 294002 blocked the(B) A phosphospecific antibody detects Akt phosphorylation of BAD
at Ser-136. Western blot using anti-BAD136 pAbs of recombinant PDGF-induced BAD phosphorylation (Figure 4A). In con-
BADS136A or BAD2SA phosphorylated by purified PKA (Boehringer trast, treatment with PD 98059, an inhibitor of MEK (a
Mannheim, 4 mU) in vitro BAD, BADS112A, BADS136A, and BAD2SA component of the Ras/MAPK pathway), or rapamycin,
phosphorylated in vitro by constitutively active HA-mD4-129Akt (Ac-
a specific inhibitor of the p70S6K pathway, did not sig-tive Akt) and unphosphorylated BAD, BADS112A, BADS136A, and
nificantly block BAD phosphorylation. PDGF-inducedBAD2SA expressed in and isolated from Balb/c 3T3 cells.
MAPK activity was inhibited by PD 98059, p70S6K activity
was inhibited by rapamycin, and Akt activity was inhib-
ited by wortmannin, demonstrating that these drugspolyclonal antibody was raised that specifically recog-
nizes BAD phosphorylated at Ser-136 and fails to recog- were effective in these cells (data not shown). Therefore,
growth factor±induced BAD phosphorylation on at leastnize BAD that is not phosphorylated at Ser-136. This
antibody was generated by injecting rabbits with an one of the two phosphorylation sites requires PI39K
pathway activity, but not the activity of MAPK or activityimmunogen composed of a synthetic phosphopeptide
containing phosphorylated BAD Ser-136. As shown in of p70S6K. These findings suggest that although Akt
and p70S6K are both dependent on PI39K activity andFigure 3B, upon Western blotting the antibodies to
phosphorylated BadSer-136 (anti-BAD136 pAbs) recog- share a similar consensus phosphorylation sequence
(RXRXXS), Akt but not p70S6K is likely to mediate BADnized BAD and BADS112A that had been phosphory-
lated by Akt in vitro, but failed to recognize mutant BAD phosphorylation in vivo. These data are also consistent
Akt Prevents BAD-Induced Death by Phosphorylation
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Figure 4A, BAD isolated from cells stably transfected
with control vector underwent a PDGF-induced shift in
mobility that reflects an increase in the BAD phosphory-
lation at two sites previously shown to be Ser-112 and
Ser-136 (Figure 4B). This mobility shift was blocked by
pretreatment of the cells with either wortmannin or LY
294002, suggesting that PI39K activity is required for
phosphorylation of at least one of the sites on BAD.
BAD isolated from cells that had been stably transfected
with the construct encoding constitutively active Akt
also underwent a PDGF-induced shift in mobility. How-
ever, unlike control cells, the BAD mobility shift was not
blocked by treatment of cells with wortmannin or LY
294002. Thus, when Akt is constitutively active, BAD
phosphorylation becomes independent of PI39K activity.
This result suggests that Akt activity issufficient to phos-
phorylate endogenous BAD in vivo, and that Akt may
mediate PI39K-dependent BAD phosphorylation. In ad-
dition, the fact that constitutive Akt activity in the ab-
sence of PDGF stimulation was incapable of inducing
a BAD mobility shift, which requires phosphorylation
simultaneously at both Ser-112 and Ser-136, suggests
that Akt phosphorylates only one site on BAD in vivo.
A second PDGF-inducible kinase or kinase cascade that
remains to be identified is most likely responsible for
the phosphorylation of BAD at the second site in these
cells. Results similar to those described were also ob-
tained in experiments using independently isolated sta-Figure 4. PI39K/Akt Pathway Mediates BAD Phosphorylation In Vivo
ble cell lines transfected with either vector or constitu-(A) PDGF treatment of Balb/c 3T3 cells results in PI39K-dependent
tively active Akt constructs (data not shown).BAD hyperphosphorylation. Anti-BAD Western blot (Santa Cruz anti-
BAD C-terminal Ab) of anti-BAD immunoprecipitates (Santa Cruz We next attempted to identify the site on BAD phos-
anti-BAD N-terminal Ab) from cells starved for 6 hr, and then either phorylated by Akt in vivo. This analysis focused on the
treated with control PBS(2 PDGF) or with 20 ng/ml PDGF (1 PDGF). ability of Akt to phosphorylate BAD at Ser-136 in vivo,
Cells were also treated with control DMSO (Veh.), PI39K inhibitor
because BAD Ser-136 is the preferred Akt phosphoryla-wortmannin (Wort.), the MEK inhibitor PD98059 (PD), the p70S6K in-
tion site in vitro. Transfection of HEK 293 cells withhibitor rapamycin (Rap.), or a combination of wortmannin and
PD98059 (Wort.1 PD). Use of the PI39K-inhibitor LY294002 also wild-type BAD and immunoprecipitation with the anti-
blocked BAD phosphorylation in this experiment (data not shown). BAD136 pAb revealed that BAD Ser-136 was basally
(B) Akt activity induces the phosphorylation of endogenous BAD in phosphorylated in these cells (Figure 4C, lane 2). This
vivo. Experiment similar to (A), except the cells used are Balb/c
basal phosphorylation was greatly enhanced when BAD3T3 cells stably transfected with either CMV-6 (Vector) or HA-mD4-
was cotransfected with a construct that encodes a con-129Akt (Active Akt).
stitutively active Akt construct, demonstrating that Akt(C) Constitutively active Akt increases BAD Ser-136 phosphoryla-
tion, and kinase-inactive Akt blocks BAD Ser-136 phosphorylation activity induces BAD Ser-136 phosphorylation in vivo
in vivo. HEK 293 cells were cotransfected with CMV-6 (vector), hem- (Figure 4C, lane 3). Importantly, phosphorylation of BAD
agglutanin-tagged constructs encoding BAD or BAD mutants
at Ser-136 was completely blocked by the expression(BADS136 and BAD2SA), and constructs encoding CMV-6 control
of a kinase-inactive Akt (Figure 4C, lane 4). The finding(Vector), constitutively active HA-mD4-129Akt (Active Akt), or a ki-
that expression of a constitutively active Akt promotesnase-inactive HA-Akt-K179M (Inactive Akt). Transfected cells were
either immunoprecipitated with an antibody directed against the the phosphorylation of BAD Ser-136, and that expres-
BAD N terminus (Santa Cruz N-term. Ab) or the BAD136 pAb and sion of kinase-inactive Akt blocks the phosphorylation
immunoprecipitates were subjected to anti-HA (12CA5 MAb) West- of BAD at Ser-136 by endogenous kinases suggests
ern blotting.
that Akt may be a major in vivo mediator of BAD Ser-
136 phosphorylation.
Additional biochemical evidence for the hypothesiswith previous findings establishing a role for Akt but not
that Akt is a relevant BAD kinase is derived from thep70S6K in mediating cell survival.
observation that the major inducible BAD kinase activityWe next investigated whether PI39K-regulated BAD
in PDGF-stimulated 3T3 cells was found to cofractionatephosphorylation is triggered by Akt in vivo. To facilitate
with both Akt immunoreactivity and Akt kinase activitythis analysis, stable Balb/c 3T3 cell lines were generated
after Mono-Q fractionation (data not shown). In addition,that express a constitutivelyactive Akt construct orcarry
preliminary evidence from cotransfection experimentsa control vector construct. We were unable to obtain
suggests that Akt and BAD associate upon overexpres-stably transfected cell lines that express the kinase-
sion in vivo. Western blotting of BAD immunoprecipi-inactive Akt construct, perhaps because expression of
tates from cells cotransfected with HA-tagged Akt con-this kinase-inactive Akt induced apoptosis, as demon-
structs and wild-type BAD demonstrated that Aktstrated in previous studies (Dudek et al., 1997; Kauff-
mann-Zeh et al., 1997). Consistent with the findings in coimmunoprecipitated with BAD, suggesting that Akt
Cell
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factors that utilize the PI39K-Akt pathway to promote
survival may suppress BAD-mediated cell death by
phosphorylating BAD at Ser-136. To investigate this
possibility,we tookadvantage of a well-established neu-
ronal culture system that has recently been used effec-
tively to characterize the importance of the PI39K/Akt
pathway in IGF-1-mediated survival (D'Mello et al., 1993;
Galli et al., 1995; Miller and Johnson, 1996; Dudek et
al., 1997). Survival of postmitotic cerebellar granule neu-
rons is promoted by defined survival factors, including
IGF-1; withdrawal of trophic support from these neu-
rons, which express BAD protein, induces synchronous
apoptotic cell death (data not shown; Dudek et al., 1997).
We previously demonstrated in these cells that IGF-1
specifically activates the PI39K-Akt pathway, and not
alternate survival pathways such as the Ras-MAPK-
p90RSK pathway, and that IGF-1-mediated induction of
the PI39K-Akt pathway is both necessary and sufficient
for IGF-1 to promote the survival of these cells (Dudek
et al., 1997).
To test thepossibility that the IGF-1-PI39K-Akt survival
pathway suppresses BAD-mediated death, we cotrans-
fected granule cells with expression constructs encod-
ing various BAD derivatives and a construct encoding
the marker gene b-galactosidase to allow the identifica-
tion of transfected neurons. As previously established,
transfected cells effectively expressed both b-gal and
Figure 5. Akt and BAD Coprecipitate the cotransfected plasmid, and the stability of b-gal
(A) Overexpresson of Akt and BAD results in interaction indepen- during apoptosis allowed effective identification of dy-
dently of Akt kinase activity. Anti-HA (12CA5 MAb) Western blot ing neurons (Dudek et al., 1997). Transfection of neurons
(upper panel) of anti-BAD immunoprecipitates (Santa Cruz N-term
with constructs encoding BAD resulted in dramatic in-Ab) prepared from HEK 293 cells cotransfected with a wild-type
duction of nuclear pyknosis and neurite fragmentation,BAD expression construct and either constitutive Akt (Myr HA-Akt),
consistent with apoptotic death (Figure 6). This deathkinase-inactive HA-AktK179M (Inactive HA-Akt), HA-Akt (Wild-type
HA-Akt), or a hemagglutanin-tagged CDK4 construct (HA-CDK4) as appeared phenotypically identical to the death induced
a negative control. Mobility of proteins on SDS±PAGE was deter- by trophic factor withdrawal. To quantitate the levels of
mined by anti-HA Western blotting (lower panel) of anti-HA immuno- death induced by BAD, in a blinded manner we scored
precipitates isolated from split lysates.
death based upon nuclear morphology, which we have(B) Overexpression of Akt and BAD results in interaction indepen-
previously found corresponds to TUNEL-positive apop-dently of an intact Ser-136. Anti-HA Western blot (12CA5 MAb) of
tosis in these cells (Dudek et al., 1997). As shown inanti-BAD immunoprecipitates (Santa Cruz N-term Ab) of HEK 293
cells cotransfected with constructs expressing either HA-Akt (Wild- Figure 6, transfection of granule cellswith wild-type BAD
type HA-Akt) or kinase-inactive HA-AktK179M (Inactive HA-Akt) and followed by 8 hr of starvation resulted in the death of
constructs expressing either CMV-6 control (Vector), wild-type BAD the large majority of transfectants (78.5% 6 2.5%
(WT BAD), BADS136A, or BAD2SA.
apoptosis, see also Figures 7A and 7B, pcDNA3 versus
wild-type BAD). We then asked whether IGF-1 inhibits
and BAD interact in vivo (Figure5A). Interestingly, forma- BAD-induced death in transfected cells. BAD-mediated
tion of this potential Akt/BAD complex did not depend death was substantially suppressed by treatment of
on the kinase activity of Akt, as a kinase-inactive mutant transfectants with the survival factor IGF-1 (37.5% 6
form of Akt associated with BAD. In addition, phosphor- 10% apoptosis, Figure 7A). To determine if IGF-1 sup-
ylation of BAD at Ser-136 is not required for the observed presses BAD-mediated death by inducing BAD phos-
Akt/BAD interaction, as both the BADS136A and the phorylation at either BAD Ser-112 or BAD Ser-136,
BAD2SA derivatives were capable of associating with expression constructs encoding BADS112A, BADS136A,
Akt (Figure 5B). It remains to be demonstrated that en- and BAD2SA were transfected into cells that were either
dogenous Akt and BAD can interact, and under what starved or treatedwith IGF-1. IGF-1 suppression of BAD-
conditions such a Akt/BAD complex is generated. How- mediated death required Ser-136, as IGF-1 blocked the
ever, taken together, these data raise the possibility that death induced by both BAD and BADS112A, but not the
Akt and BAD proteins may interact, and provide support death induced by BADS136A and BAD2SA. Thus, IGF-1,
for the hypothesis that Akt is an in vivo BAD kinase. which promotes survival via PI39K and Akt, inhibits BAD-
mediated death via site-specific phosphorylation of BAD
IGF-1 and Akt Suppress BAD-Mediated at Ser-136. This IGF-1 survival effect does not require
Cell Death in Primary Neurons in a the presence of the Ser-112 site on BAD, suggesting that
Ser-136-Dependent Manner the major kinases mediating the IGF-1 survival effect
The finding that Akt activation triggers BAD Ser-136 require the presence of only BAD Ser-136 to block BAD
induction of death.phosphorylation in vitro and invivo suggests that growth
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Figure 7. IGF-1 and Akt Suppress BAD-Mediated Death in Primary
Neurons in a BAD Ser-136-Dependent MannerFigure 6. Transfection of Granule Cells with Active Akt Suppresses
(A) IGF-1 suppresses BAD-mediated death of transfected neuronsBAD-Mediated Death
in a BAD Ser-136-dependent manner. Quantitation of percentAnti-b-gal immunostaining (red) of cerebellar granule cells cotrans-
apoptosis based upon nuclear morphology of positively transfectedfected with expression plasmids encoding the marker b-galactosi-
neurons (as identified by b-gal staining) expressing constructs en-dase and wild-type BAD excluding (upper panel) or including (lower
coding either wild-type BAD (WT BAD), BADS112A, BADS136A, orpanel) a construct encoding constitutively active HA-mD4-129Akt
BAD2SA. After transfection, neurons were allowed to recover over-(Active Akt). Nuclear morphology was visualized by bisbenzamide
night, and then placed in either starvation media or IGF-1-containingcostaining (blue). White arrows indicate nuclei of transfected cells.
media (50 ng/ml) for 8 hr, fixed, and scored in a blinded manner. At
this time point (8 hr), cells that were not tranfected with BAD showed
no increase in cell death in the presence of IGF-1, compared to the
basal level of apoptosis seen in full survival medium (data notGiven the established role for PI39K and Akt in mediat-
shown). Bars indicate the standard error of the mean; each baring IGF-1 survival in cerebellar granule cells, and the
represents at least 400 scored transfected cells.demonstration that Akt can phosphorylate BAD in vitro
(B) Akt suppresses BAD-mediated death of transfected neurons inand in vivo, we examined if Akt activity is sufficient to
a BAD Ser-136-dependent manner. Quantitation similar to (A) of
suppress BAD-induced cell death in the absence of neurons cotransfected with expression constructs encoding either
IGF-1 in a Ser-136-dependent manner. To test whether vector (pECEC) or a constitutively active HA-mD4-129Akt (Active
Akt) and constructs expressing either CMV-6 control (Vector), wild-a constitutively active Akt could substitute for IGF-1 in
type BAD (WT BAD), BADS112A, BADS136A, or BAD2SA. Neuronspreventing BAD-mediated death, we transfected con-
were treated and stained as in (A), but treatment time in eitherstructs encoding BAD and an active form of Akt into
starvation media or full survival media (10% bovine calf serum 1
granule cells. Nearly all of the neurons (97.7% 6 1.3%) 25 mM KCl) was 16 hr. Bars indicate the standard error of the mean;
that were transfected with BAD and deprived of survival each bar represents at least 500 scored transfected cells from three
factors for 16 hr, as quantitated in Figure 7B, underwent independent experiments.
apoptosis (versus 41.0% 6 5.5% for pcDNA3 vector
alone). BAD-mediated death was almost wholly sup-
pressed by cotransfection with a constitutive Akt deriva- death was also tested in the presence of survival media
containing serum and depolarizing concentrations oftive (8.3% 6 1.2%, ANOVA with Bonferroni correction,
p , 0.0001) (Figure 7B). Neurons cotransfected with Akt KCl, conditions that likely activate multiple survival path-
ways. Transfected BAD was capable of killing neuronsand BAD appeared healthy and robust, with elaborate
processes, well-defined nuclei, and large soma (Figure cultured in full survival media, although the activation
of multiple survival pathwaysÐone or more of which6). To demonstrate that Akt could suppress BAD-medi-
ated death that was due entirely to BAD's death-promot- may act independently of BADÐcaused partialsuppres-
sion of BAD-mediated death (32.0% 6 2.3%, Figure 7B).ing activity, the ability of Akt to suppress BAD-mediated
Cell
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Under these conditions, the death that was detected
was almost totally blocked by cotransfection of a consti-
tutive Akt derivative (5.0% 6 1%, ANOVA with Bonfer-
roni correction p , 0.0001). Thus,Akt activity is sufficient
to dramatically suppress the BAD-mediated death of
transfected neurons.
The phosphorylation sites involved in the Akt-mediated
inhibition of BAD-induced death were examined by
transfecting neurons with expression vectors encoding
BADS112A, BADS136A, and BAD2SA. Each of these
constructs induced the death of essentially all trans-
fected neurons when the cells were deprived of survival
factors (for example, BADS112A induced apoptosis in
93.7% 6 3.4% of transfectants, Figure 7B) . However,
constitutive Akt was capable of suppressing the death
induced by BAD only when the BAD Ser-136 site was
intact. The death induced by BAD and BADS112A was
effectively suppressed by the cotransfection of a consti-
tutively active Akt construct; in contrast, death induced
by BAD constructs in which Ser-136 was converted to
alanine (BADS136A and BAD2SA) was not rescued by
cotransfection with an active Akt. Consistent with the
findings in the absence of survival factors, expression
of constitutive Akt also suppressed BAD-induced apop-
tosis in full survival media in a Ser-136-dependent man-
ner (Figure 7B). These findings support the conclusion
that IGF-1 and its target kinase Akt potently block BAD- Figure 8. Model of Survival Signaling to BAD
induced apoptosis and promote survival by triggering The delineated signaling pathway mediates survival by the sequen-
tial activation of growth factor receptors, PI39K, and Akt, whichphosphorylation of BAD at Ser-136.
phosphorylates BAD Ser-136. Both PI39K- and BAD-independent
survival mechanisms likely also exist.Discussion
In other cell types, such as Il-3-dependent hematopoi-Experiments in this study reveal that Akt phosphorylates
etic cells, prevention of cell death may involve both BADBAD both in vitro and in vivo and that Akt-mediated
Ser-112 and BAD Ser-136 (Zha et al., 1996). It may bephosphorylation of BAD effectively blocks BAD-induced
that in these cells Akt is involved in BAD Ser-112 phos-cell death. Taken together, these findings demonstrate
phorylation. Alternatively, Il-3 and other stimuli such asthat activation of growth factor receptors can suppress
PDGF may promote survival by activating other kinaseapoptosis induced by BAD through a pathway involving
cascades to phosphorylate BAD at either Ser-112 orthe sequential induction of phosphoinositide-39-OH ki-
Ser-136. A number of signaling molecules in additionnase activity, Akt activity, and finally BAD phosphoryla-
to Akt have been identified as potential mediators oftion. Because both PI39K and Akt have been shown to
survival stimuli, including PKA, components of the Ras-promote survival in a variety of cellular contexts, the
MAPK-p90RSK pathway, and the calcium/calmodulin-PI39K-Akt-BAD pathway may represent a general mech-
dependent kinases (Rukenstein et al., 1991; Hack et al.,anism by which growth factors promote cell survival.
1993; Xia et al., 1995). Preliminary evidence suggestsIn addition, these findings implicate a particular phos-
that p90RSK or purified CaMKII can phosphorylate BADphorylation site on BAD, serine 136, in the suppression
at either Ser-112 or Ser-136 in vitro (data not shown).of BAD-mediated death by Akt. We show by a number
Thus, BAD may be a general target of kinases inducedof criteria that Akt is a potent BAD Ser-136 kinase in
by a diverse set of survival stimuli including growth fac-vitro. Since constitutively active Akt phosphorylates
tors and cytokines, agents that cause increases in intra-both endogenous and transfected BAD, and because
cellular calcium, and neurotransmitters whose effectsdisruption of Akt kinase activity results in the loss of
are mediated by adenylate cyclases.BAD Ser-136 phosphorylation, Akt is also likely a major
The presence of two phosphorylation sites on BADBAD Ser-136 kinase in vivo. This conclusion is sup-
also suggests that the simultaneous activation of differ-ported by the observation that in cerebellar granule
ent survival pathways may result in the concomitantcells, an intact BAD Ser-136 phosphorylation site is re-
phosphorylation of BAD Ser-112 and Ser-136 by differ-quired for both IGF-1 and its downstream kinase Akt to
ent kinase cascades (Figure 8). The relevance of suchprevent BAD-mediated cell death. In contrast, Akt failed
a model is supported by the observation that optimalto significantly phosphorylate BAD at Ser-112, and the
cell survival in vitro is often best supported by a combi-mutation of BAD Ser-112 to an alanine had no effect on
nation of survival factors, rather than a single factorthe ability of IGF-1 or Akt to suppress BAD-mediated
(Barres et al., 1993; Meyer-Franke et al., 1995).cell death. These observations suggest that Akt primarily
The phosphorylation of BAD may lead to the preven-triggers BAD phosphorylation at Ser-136 and that phos-
phorylation at this site is sufficient to promote survival. tion of cell death via a mechanism that involves the
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selective association of the phosphorylated forms of Therefore, Akt may promote both survival and the func-
tional integrity of neurons and other cells by phosphory-BAD with 14-3-3 protein isoforms. This BAD/14-3-3 in-
teraction can occur when BAD becomes phosphory- lating a number of targets, including BAD and other
substrates that remain to be identified.lated at Ser-112 and/or Ser-136, and the induced associ-
ation of BAD with 14-3-3 appears to prevent BAD
Experimental Proceduresassociation with BCL-XL or BCL-2. Preliminary evidence
suggests that constitutively active Akt can induce the
Materialsassociation of BAD and 14-3-3z, and that kinase-inactive
Throughout this paper, all Akt constructs are based on the wild-
Akt does not induce this association event. In addition, type Akta sequence. Unless otherwise noted, wortmannin was used
Akt-induced BAD/14-3-3z association depends on the at a concentration of 20 nM, rapamycin at a concentration of 20
presence of BAD Ser-136, as mutation of Ser-136 to nM, PD 98059 at a concentration of 20 mM, and LY 294002 at a
concentration of 10 mM.alanine abolishes the BAD/14-3-3z interaction (data not
shown). It has been proposed that in the absence of
AntibodiesBAD phosphorylation, BAD may bind toBCL-XL or BCL-2
To generate anti-BAD136 pAg, a phosphopeptide of the sequenceand suppress survival by inducing BAX homodimer for-
CSPFRGRSRpSAPPN (Tufts Synthesis Facility, Tufts Medical
mation. The prodeath function of BAD could also be a School, Boston, MA), was synthesized and coupled to keyhole lim-
direct consequence of BAD's heterodimerization with pet hemocyanin (Pierce). To generate anti-BAD136 pAbs, this anti-
BCL-XL or BCL-2, and may not involve BAX heterodimer- gen was injected into New Zealand White rabbits (Covance Re-
search Products, Denver, PA), from which serum was collectedization (Yang et al., 1995; Gajewskiand Thompson,1996;
approximately every three weeks. Serum was affinity-purified byZha et al., 1996). The role for BAD in regulating death
passing it over a protein A±Sepharose column (Pharmacia), elutingmay not be ubiquitous, as there are cell types in which
the bound pAbs with 100 mM glycine (pH 2.5), passing this eluate
BCL-XL and BCL-2 do not play significant roles in over an agarose-iodoacetyl column (Pierce) to which was coupled
survival, and in these cell types overexpression of BAD a synthetic peptide of the sequence CSPFRGRSRSAPPN (Biopoly-
does not induce death (Yang et al., 1995). However, mers Laboratory, HarvardMedical School, Boston, MA), and collect-
ing the flow-through.genetic and cell biological evidence suggests that
Other antibodies used in this study include polyclonal antiBCL-XL,BCL-2, and BAX likely have broad and important
N-terminal BAD antibody sc-941 (Santa Cruz), polyclonal antiroles in organismal physiology, and thus, the prevention
C-terminal BAD antibody sc-943 (Santa Cruz), monoclonal anti-BAD
of BAD-related death by growth factor regulation of BAD antibody B31420 (Transduction Labs), polyclonal anti-Akt1 sc-1618
phosphorylation may be a major mechanism by which (Santa Cruz), polyclonal anti-Akt1 antibody 31 (generous gift of Dr.
growth factors induce cell survival. Morris Birnbaum), and monoclonal anti-hemagglutanin antibody
12CA5 (Boehringer Mannheim).Phosphorylated BAD may also play an active role in
promoting survival. Although there is as yet no direct
BAD Plasmid Cloning, Mutagenesis, and Protein Purificationevidence supporting this hypothesis, an active survival
The full-length murine BAD cDNA was cloned by RT±PCR offunction for BAD is suggested by the finding that the
RNA isolated from adult mouse whole brain using a forward primer
interaction between BAD and 14-3-3 proteins is induced of sequence TCC-AGG-ATC-CAA-ATG-GGA-ACC and a reverse
by phosphorylation at BAD Ser-136. 14-3-3 isoforms primer of sequence CGT-CGA-ATT-CGC-CCA-CAC-CCA-ATA-
have been found to associate with a number of cellular TGG-CG. The cloned cDNA was digested with BamHI and EcoRI
and subcloned into the polylinker of the vector pCDNA3. The HAsignaling molecules, including KSR, cdc25, Raf-1, and
tag was added to this cDNA by PCR amplifying the full-length BADPI39K (reviewed in Morrison, 1994; Burbelo and Hall,
cDNA with the forward primer 59-GCC-GGT-ACC-ATG-TAC-CCA-1995). Given our preliminary evidence that overexpres-
TAC-GAT-GTT-CCA-GAT-TAC-G CT-GGA-ACC-CCA-AAG-C AG-
sion of BAD and Akt can result in the formation of a CCC-39, which contains the nucleotide sequence for the HA tag
BAD/Akt complex, it is possible that BAD brings Akt linked to the second amino acid of BAD. This cDNA was digested
to the 14-3-3 complex, where Akt may phosphorylate with KpnI and EcoRI and cloned into pCDNA3. Point mutation of
Ser-112 and Ser-136 was accomplished by PCR primer mutagene-additional signaling molecules to promote survival. Fur-
sis. To generate wild-type and mutant polyhistidine-tagged BADther dissection of 14-3-3 protein complexes that assem-
bacterial expression constructs, a NdeI site was generated near theble after growth-factor treatment may reveal novel roles
BAD start codon. The gene was then cloned into the NdeI and
for phosphorylated BAD and Akt in promoting survival. BamHI sites of a pET-16b expression vector. The mutant poly His-
The identification of BAD as an Akt substrate expands tagged BAD constructs were generated by swapping the mutant
the list of in vivo Akt targets. Because Akt mediates region between AvrII and BamHI sites with the corresponding region
of wild-type BAD. The sequences of all wild-type and mutant BADmultiple physiological responses in addition to survival,
constructs were verified by automated sequencing. Wild-type andincluding GLUT4 translocation and changes in glycogen
mutant BAD proteins were inducibly expressed in E. coli strain BL21metabolism, Akt likely has additional substrates in vivo
HMS175 (DE5)pLysS and purified over ProBond resin (Invitrogen). All
(Cross et al., 1995; Kohn et al., 1996). These novel targets PCR primers were synthesized at the Harvard Biopolymers Facility
could also play a role in promoting survival and pre- (Harvard Medical School, Boston, MA), and all restriction enzymes
venting cell death. The possibility that Akt phosphory- and polymerases were obtained from New England Biolabs.
lates multiple substrates is interesting in light of the
Cell Lines, Transfection, and Stimulation Protocolsobservation that neuronal survival promoted by blocking
Balb/c 3T3 and 293 cells were transfected by treating the cells withthe terminal stages of apoptosis frequently results in
calcium phosphate precipitates for 12 hr, then changing to freshneurons that survive butare shrunken and nonfunctional
media for 12 hr, and lysing the cells. COS cells were transfected by
(Deckwerth et al., 1996; Deshmukh et al., 1996). In con- the DNA/DEAE-dextran (Pharmacia)/chloroquine (Sigma) method.
trast, neurons whose survival is promoted by Akt activity PDGF stimulation of 3T3 cells was accomplished by starving the
are healthy and appear functional, with arborized pro- cells in DMEM containing 0% FBS for 6 hr, and injecting control
PBS or PDGF-BB (Upstate Biotechnology Incorporated) into thecesses and large nuclei (this study; Dudek et al., 1997).
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dish at a final concentration of 20 ng/ml. Balb/c 3T3 stable transfec- Barres, B.A., Schmid, R., Sendnter, M., and Raff, M.C. (1993). Multi-
ple extracellular signals are required for long-term oligodendrocytetants were generated by cotransfecting either CMV-6 or HA-
mD4-129Akt with the plasmid pBABE-PURO (1:10 ratio) by the cal- survival. Development 118, 283±295.
cium phosphate method in standard media supplemented with 1.25 Bellacosa, A., Testa, J.R., Staal, S.P., and Tsichlis, P.N. (1991). A
mg/ml puromycin (Sigma). Individual clones werepicked and expres- retroviral oncogene, akt, encoding a serine threonine kinase con-
sion of the Akt plasmid was detected by anti-HA immunoblotting. taining an SH2-like region. Science 254, 274±277.
Boise, L.H., Gottschalk, A.R., Quintans, J., and Thompson, C.B.
Protein Methods (1995). Bcl-2 and Bcl-2-related proteins in apoptosis regulation.
Immunoprecipitations, kinase assays, and Western blotting were Curr. Top. Microbiol. Immunol. 200, 107±121.
carried out as described previously (Dudek et al., 1997). Two-dimen-
Burbelo, P.D., and Hall, A. (1995). 14-3-3 proteins. Hot numbers insional tryptic mapping was carried out by isolating, treating the
signal transduction. Curr. Biol. 5, 95±96.pellet with performic acid, trypsinizing overnight with TPCK-trypsin
Burgering, B.M., and Coffer, P.J. (1995). Protein kinase B (c-Akt) in(Worthington Enzymes), washing extensively in water, and spotting
phosphatidylinosotol-3-OH kinase signal transduction. Nature 376,onto cellulose TLC plates (VWR). Electrophoresis was carried out
599±602.in pH 8.9 for 30 min at 1000 V using a Hunter TLC apparatus, and
chromatography was carried out in a phosphochromatography Carpenter, C.L., and Cantley, L.C. (1996). Phosphoinositide kinases.
buffer containing 37.5% n-butanol, 25% pyridine, and 0.75% glacial Curr. Opin. Cell Biol. 8, 153±158.
acetic acid. Control Ser-112 (HSpSYPAGTEEDEGMEEELSPFR) and Chinnaiyan, A.M., and Dixit, V.M. (1996). The cell-death machine.
Ser-136 (pSAPPNLWAAQR) tryptic phosphopeptides were synthe- Curr. Biol. 6, 555±562.
sized and run as controls (Dana Farber Molecular Biology Core Coffer, P.J., and Woodgett, J.R. (1992). Molecular cloning and char-
Facility, Boston, MA). acterisation of a novel putative protein-serine kinase related to the
cAMP-dependent and protein kinase C families. Eur. J. Biochem.
Granule Cell Cultures, Immunostaining, Transfection, 205, 1217.
and Survival Assays
Cross, D.A., Alessi, D.R., Cohen, P., Andjelkovich, M., and Hem-Neuronal cultures and scoring were carried out as described pre-
mings, B. (1995). Inhibition of glycogen synthase kinase-3 by insulinviously (Dudek et al., 1997). Cells were transfected at DIV 4-5 essen-
mediated by protein kinase B. Nature 378, 785±789.tially as in Dudek et al., 1997, except that transfections were done
D'Mello, S.R., Galli, C., Ciotti, T., and Calissano, P. (1993). Inductionin Hank's salt-buffered MEM (at pH 7.85) in ambient air. One day
of apoptosis in cerebellar granule neurons by low potassium: inhibi-after transfection, cells were incubated an additional 8 or 16 hr in
tion of death by insulin-like growth factor I and cAMP. Proc. Natl.treatment solutions, then fixed with paraformaldehyde, blocked in
Acad. Sci. USA 90, 10989±10993.3% BSA solution, and immunostained.
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